Facebook shares plummeted after the Cambridge Analytica scandal came to light, but the recent pullback has created a buying opportunity, said Mark Mahaney, Managing Director at RBC Capital. The internet analyst said this could be the stock's “most attractive price point” in years.
Investors have been concerned the backlash over the incident, which Facebook says may have impacted as many as 87 million users, could lead to government regulation and advertisers leaving the platform. While the company could see a decline in daily active users, Mahaney said any losses would be modest.
The company has a “PR issue, not a fundamental issue,” Mahaney told Cheddar Wednesday. That’s why the social media giant is his top pick in the internet space.
Facebook could get back on Wall Street's good side when it reports earnings next Wednesday, April 25th. If Facebook can demonstrate that it escaped the Cambridge Analytica scandal without a significant drop in user engagement, advertisers might decide to keep pumping money into the platform.
Mahaney said the #DeleteFacebook campaign was an interesting movement, but added that he thinks it will be extremely short-lived.
For full interview, [click here](https://cheddar.com/videos/top-facebook-analyst-bullish-ahead-of-q1-earnings).
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
A group of Democratic Texas lawmakers is asking Elon Musk to delay his rollout of driverless ‘robotaxis’ in the state this weekend to assure the vehicles are safe enough.
The billionaire slated to takeover the controlling interest in the Los Angeles Lakers has built a career leading businesses investing in everything from sports franchises to artificial intelligence.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
